{"entity":{"type":"insider","cik":"0001328288","url":"/insider/0001328288","json_url":"/insider/0001328288.json","name":"Gergel Ivan P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":18,"first":"2005-06-21","last":"2017-10-03","span_basis":"filed_date"},"name_variants":[{"name":"Gergel Ivan P.","source":"filing","n_filings":16,"first_seen":"2010-12-07","last_seen":"2017-10-03"},{"name":"Gergel Ivan","source":"filing","n_filings":2,"first_seen":"2005-06-21","last_seen":"2007-02-16"}],"transactions":[{"id":5038284,"accession":"0001209191-17-055353","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-055353","line_url":"/filing/0001209191-17-055353#line-4","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56704.0,"shares_display":"56,704","price_per_share":24.21,"price_display":"24.21","price_state":"stated","total_value":1372803.84,"total_display":"1,372,803.84","total_whole":"1,372,804","shares_owned_after":41575.0,"shares_owned_after_display":"41,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-03","scope":"insider"},{"id":5038274,"accession":"0001209191-17-055353","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-055353","line_url":"/filing/0001209191-17-055353#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43296.0,"shares_display":"43,296","price_per_share":24.04,"price_display":"24.04","price_state":"stated","total_value":1040835.84,"total_display":"1,040,835.84","total_whole":"1,040,836","shares_owned_after":41575.0,"shares_owned_after_display":"41,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-29","filed_date":"2017-10-03","scope":"insider"},{"id":4489137,"accession":"0001209191-17-049664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049664","line_url":"/filing/0001209191-17-049664#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1997.0,"shares_display":"1,997","price_per_share":19.32,"price_display":"19.32","price_state":"stated","total_value":38582.04,"total_display":"38,582.04","total_whole":"38,582","shares_owned_after":41575.0,"shares_owned_after_display":"41,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-18","scope":"insider"},{"id":4417251,"accession":"0001209191-17-045842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-045842","line_url":"/filing/0001209191-17-045842#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54920.0,"shares_display":"54,920","price_per_share":21.1,"price_display":"21.10","price_state":"stated","total_value":1158812.0,"total_display":"1,158,812.00","total_whole":"1,158,812","shares_owned_after":43572.0,"shares_owned_after_display":"43,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-18","filed_date":"2017-07-20","scope":"insider"},{"id":4906116,"accession":"0001209191-17-045121","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-045121","line_url":"/filing/0001209191-17-045121#line-4","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36691.0,"shares_display":"36,691","price_per_share":21.09,"price_display":"21.09","price_state":"stated","total_value":773813.19,"total_display":"773,813.19","total_whole":"773,813","shares_owned_after":43572.0,"shares_owned_after_display":"43,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-12","filed_date":"2017-07-13","scope":"insider"},{"id":4906108,"accession":"0001209191-17-045121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-045121","line_url":"/filing/0001209191-17-045121#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8389.0,"shares_display":"8,389","price_per_share":21.04,"price_display":"21.04","price_state":"stated","total_value":176504.56,"total_display":"176,504.56","total_whole":"176,505","shares_owned_after":43572.0,"shares_owned_after_display":"43,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-11","filed_date":"2017-07-13","scope":"insider"},{"id":5280649,"accession":"0001209191-17-033766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033766","line_url":"/filing/0001209191-17-033766#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450.0,"shares_display":"1,450","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":28347.5,"total_display":"28,347.50","total_whole":"28,348","shares_owned_after":43572.0,"shares_owned_after_display":"43,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-18","scope":"insider"},{"id":4860223,"accession":"0001209191-17-012403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-012403","line_url":"/filing/0001209191-17-012403#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":13.14,"price_display":"13.14","price_state":"stated","total_value":19144.98,"total_display":"19,144.98","total_whole":"19,145","shares_owned_after":45022.0,"shares_owned_after_display":"45,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":3046330,"accession":"0001209191-16-151301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151301","line_url":"/filing/0001209191-16-151301#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":848.0,"shares_display":"848","price_per_share":13.96,"price_display":"13.96","price_state":"stated","total_value":11838.08,"total_display":"11,838.08","total_whole":"11,838","shares_owned_after":26479.0,"shares_owned_after_display":"26,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-18","scope":"insider"},{"id":2251145,"accession":"0001209191-16-137608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-137608","line_url":"/filing/0001209191-16-137608#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1685.0,"shares_display":"1,685","price_per_share":17.56,"price_display":"17.56","price_state":"stated","total_value":29588.6,"total_display":"29,588.60","total_whole":"29,589","shares_owned_after":27327.0,"shares_owned_after_display":"27,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider"},{"id":2924228,"accession":"0001209191-16-121346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-121346","line_url":"/filing/0001209191-16-121346#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":432.0,"shares_display":"432","price_per_share":13.58,"price_display":"13.58","price_state":"stated","total_value":5866.56,"total_display":"5,866.56","total_whole":"5,867","shares_owned_after":1512.0,"shares_owned_after_display":"1,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-17","filed_date":"2016-05-18","scope":"insider"},{"id":2052543,"accession":"0001209191-16-100222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-100222","line_url":"/filing/0001209191-16-100222#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":556.0,"shares_display":"556","price_per_share":11.92,"price_display":"11.92","price_state":"stated","total_value":6627.52,"total_display":"6,627.52","total_whole":"6,628","shares_owned_after":694.0,"shares_owned_after_display":"694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-18","scope":"insider"},{"id":6442170,"accession":"0001209191-14-019571","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-019571","line_url":"/filing/0001209191-14-019571","is_derivative":false,"issuer_cik":"0001328288","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001328288","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (EVP, R&D and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D and CSO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75637.0,"shares_display":"75,637","price_per_share":72.47,"price_display":"72.47","price_state":"stated","total_value":5481413.39,"total_display":"5,481,413.39","total_whole":"5,481,413","shares_owned_after":27649.0,"shares_owned_after_display":"27,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-11","scope":"insider","n_lines":4},{"id":4303145,"accession":"0001209191-13-022758","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-13-022758","line_url":"/filing/0001209191-13-022758","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO HEALTH SOLUTIONS INC.","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (EVP, R&D and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D and CSO","security_title":"Common Stock, par value, $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138225.0,"shares_display":"138,225","price_per_share":36.45441439681679,"price_display":"36.45","price_state":"stated","total_value":5038911.43,"total_display":"5,038,911.43","total_whole":"5,038,911","shares_owned_after":33035.0,"shares_owned_after_display":"33,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-24","filed_date":"2013-04-26","scope":"insider","n_lines":4},{"id":9191812,"accession":"0001209191-11-026142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-026142","line_url":"/filing/0001209191-11-026142#line-2","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Common Stock, par value, $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":39.39,"price_display":"39.39","price_state":"stated","total_value":492375.0,"total_display":"492,375.00","total_whole":"492,375","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-03","filed_date":"2011-05-04","scope":"insider"},{"id":9081985,"accession":"0001209191-11-015182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-015182","line_url":"/filing/0001209191-11-015182#line-2","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Common Stock, par value, $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30603.0,"shares_display":"30,603","price_per_share":35.77,"price_display":"35.77","price_state":"stated","total_value":1094669.31,"total_display":"1,094,669.31","total_whole":"1,094,669","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-02","filed_date":"2011-03-03","scope":"insider"},{"id":9151051,"accession":"0001209191-11-013030","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-013030","line_url":"/filing/0001209191-11-013030#line-4","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Common Stock, par value, $.01 pershare","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15742.0,"shares_display":"15,742","price_per_share":33.59,"price_display":"33.59","price_state":"stated","total_value":528773.78,"total_display":"528,773.78","total_whole":"528,774","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-24","filed_date":"2011-02-25","scope":"insider"},{"id":7306622,"accession":"0001209191-10-058872","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-058872","line_url":"/filing/0001209191-10-058872","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001328288","owner_name":"Gergel Ivan P.","owner_display_name":"Gergel Ivan P.","owner_url":"/insider/0001328288","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Common Stock, par value, $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55603.0,"shares_display":"55,603","price_per_share":36.53,"price_display":"36.53","price_state":"stated","total_value":2031177.59,"total_display":"2,031,177.59","total_whole":"2,031,178","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-03","filed_date":"2010-12-07","scope":"insider","n_lines":2},{"id":7788972,"accession":"0001293301-07-000006","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001293301-07-000006","line_url":"/filing/0001293301-07-000006","is_derivative":false,"issuer_cik":"0000038074","issuer_name":"FOREST LABORATORIES INC","issuer_ticker":"FRX","issuer_name_source":null,"issuer_url":"/issuer/0000038074","owner_cik":"0001328288","owner_name":"Gergel Ivan","owner_display_name":"Gergel Ivan","owner_url":"/insider/0001328288","role":"Officer (SVP Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (SVP Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Scientific Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32250.0,"shares_display":"32,250","price_per_share":53.41886821705426,"price_display":"53.42","price_state":"stated","total_value":1722758.5,"total_display":"1,722,758.50","total_whole":"1,722,759","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-14","filed_date":"2007-02-16","scope":"insider","n_lines":9},{"id":1311617,"accession":"0001293301-05-000002","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001293301-05-000002","line_url":"/filing/0001293301-05-000002","is_derivative":false,"issuer_cik":"0000038074","issuer_name":"FOREST LABORATORIES INC","issuer_ticker":"FRX","issuer_name_source":null,"issuer_url":"/issuer/0000038074","owner_cik":"0001328288","owner_name":"Gergel Ivan","owner_display_name":"Gergel Ivan","owner_url":"/insider/0001328288","role":"Officer (Sr VP - Chief Sci. Officer)","role_mark":"O","role_mark_label":"Officer (Sr VP - Chief Sci. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP - Chief Sci. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":40.225125,"price_display":"40.23","price_state":"stated","total_value":643602.0,"total_display":"643,602.00","total_whole":"643,602","shares_owned_after":7900.0,"shares_owned_after_display":"7,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-17","filed_date":"2005-06-21","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Officer (SVP & Chief Medical Officer)","n_filings":10,"first_seen":"2016-02-18","last_seen":"2017-10-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001593034","name":"Endo International plc","url":"/issuer/0001593034","role":"Officer (EVP, R&D and CSO)","n_filings":1,"first_seen":"2014-03-11","last_seen":"2014-03-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001100962","name":"ENDO HEALTH SOLUTIONS INC.","url":"/issuer/0001100962","role":"Officer (EVP, R&D and CSO)","n_filings":5,"first_seen":"2010-12-07","last_seen":"2013-04-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000038074","name":"FOREST LABORATORIES INC","url":"/issuer/0000038074","role":"Officer (SVP Scientific Affairs)","n_filings":2,"first_seen":"2005-06-21","last_seen":"2007-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001328288","retrieved_at":"2026-08-22T15:53:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}